BioNexus Gene Lab Corp. Deferred Tax Liabilities, Gross
BioNexus Gene Lab Corp. (BGLC) had Deferred Tax Liabilities, Gross of $38.47 thousand as of 2019-06-30, per its 10-Q filed 2019-08-09.
Discontinued › Notes
us-gaap:DeferredIncomeTaxLiabilities · last filed 2019-08-09
- 2019-06-30: Deferred Tax Liabilities, Gross $38.47K.
- 2018-12-31: Deferred Tax Liabilities, Gross $37.10K.
| Period end | Deferred Tax Liabilities, Gross |
|---|---|
| 2019-06-30 | $38.47K 10-Q · filed 2019-08-09 |
| 2018-12-31 | $37.10K 10-Q · filed 2019-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |